CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 5 enrolled
Drug / intervention
Hypofractionated Radiotherapyradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03841435
NCT03841435N/ACompleted
CompareCT.gov

Feasibility Study of Hypofractionated Radiotherapy in the Setting of Recurrent Diffuse Intrinsic Pontine Glioma

University of Cincinnati·interventional·Posted Feb 15, 2019·Updated Sep 13, 2023

In Brief

A clinical study evaluating Hypofractionated Radiotherapy for Recurrent Diffuse Intrinsic Pontine Glioma. Completed, enrolled 5 participants across 1 site.

Detailed Summary

This study evaluates the feasibility of hypofractionated radiotherapy (RT) in the palliative treatment of recurrent diffuse intrinsic pontine glioma (DIPG). Participants will receive 15 Gy in 3 fractions as opposed to the standard 20 Gy in 10 fractions.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRecurrent Diffuse Intrinsic Pontine Glioma
CountriesUnited States
CollaboratorsChildren's Hospital Medical Center, Cincinnati

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedFeb 15, 2019
Enrollment StartJan 31, 2018
Primary CompletionMar 3, 2023
TodayJul 2, 2026
Enrollment to primary: 5.1 yearsPosted 7.4 years ago

Interventions

Hypofractionated Radiotherapyradiation

Radiotherapy Treatment, totaling 15 Gy, will be given in 3 fractions over 2 weeks.